Drug Shortage Report for RANITIDINE INJECTION USP

Last updated on 2020-06-22 History
Report ID 93458
Drug Identification Number 02256711
Brand name RANITIDINE INJECTION USP
Common or Proper name RANITIDINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RANITIDINE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 50ml
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-08-19
Estimated end date 2020-06-12
Actual end date 2020-06-12
Shortage status Resolved
Updated date 2020-06-22
Company comments Product released Tuesday February 4th 2020 and available under a protective allocation at 200% of historical monthly volumes at this time.
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2020-06-22 French Compare
v21 2020-06-22 English Compare
v20 2020-05-11 French Compare
v19 2020-05-11 English Compare
v18 2020-05-08 French Compare
v17 2020-05-08 English Compare
v16 2020-05-04 French Compare
v15 2020-05-04 English Compare
v14 2020-04-07 French Compare
v13 2020-04-07 English Compare
v12 2020-03-06 French Compare
v11 2020-03-06 English Compare
v10 2020-02-15 French Compare
v9 2020-02-15 English Compare
v8 2020-02-06 French Compare
v7 2020-02-06 English Compare
v6 2020-02-06 French Compare
v5 2020-02-06 English Compare
v4 2019-10-15 French Compare
v3 2019-10-15 English Compare

Showing 1 to 20 of 22